Cargando…
Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection
Innate immune cells quickly infiltrate the site of pathogen entry and not only stave off infection but also initiate antigen presentation and promote adaptive immunity. The recruitment of innate leukocytes has been well studied in the context of extracellular bacterial and fungal infection but less...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135835/ https://www.ncbi.nlm.nih.gov/pubmed/30209334 http://dx.doi.org/10.1038/s41598-018-32011-2 |
_version_ | 1783354885181276160 |
---|---|
author | Seelige, Ruth Saddawi-Konefka, Robert Adams, Nicholas M. Picarda, Gaëlle Sun, Joseph C. Benedict, Chris A. Bui, Jack D. |
author_facet | Seelige, Ruth Saddawi-Konefka, Robert Adams, Nicholas M. Picarda, Gaëlle Sun, Joseph C. Benedict, Chris A. Bui, Jack D. |
author_sort | Seelige, Ruth |
collection | PubMed |
description | Innate immune cells quickly infiltrate the site of pathogen entry and not only stave off infection but also initiate antigen presentation and promote adaptive immunity. The recruitment of innate leukocytes has been well studied in the context of extracellular bacterial and fungal infection but less during viral infections. We have recently shown that the understudied cytokine Interleukin (IL)-17D can mediate neutrophil, natural killer (NK) cell and monocyte infiltration in sterile inflammation and cancer. Herein, we show that early immune cell accumulation at the peritoneal site of infection by mouse cytomegalovirus (MCMV) is mediated by IL-17D. Mice deficient in IL-17D or the transcription factor Nuclear factor (erythroid-derived 2)-like 2 (Nrf2), an inducer of IL-17D, featured an early decreased number of innate immune cells at the point of viral entry and were more susceptible to MCMV infection. Interestingly, we were able to artificially induce innate leukocyte infiltration by applying the Nrf2 activator tert-butylhydroquinone (tBHQ), which rendered mice less susceptible to MCMV infection. Our results implicate the Nrf2/IL-17D axis as a sensor of viral infection and suggest therapeutic benefit in boosting this pathway to promote innate antiviral responses. |
format | Online Article Text |
id | pubmed-6135835 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-61358352018-09-15 Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection Seelige, Ruth Saddawi-Konefka, Robert Adams, Nicholas M. Picarda, Gaëlle Sun, Joseph C. Benedict, Chris A. Bui, Jack D. Sci Rep Article Innate immune cells quickly infiltrate the site of pathogen entry and not only stave off infection but also initiate antigen presentation and promote adaptive immunity. The recruitment of innate leukocytes has been well studied in the context of extracellular bacterial and fungal infection but less during viral infections. We have recently shown that the understudied cytokine Interleukin (IL)-17D can mediate neutrophil, natural killer (NK) cell and monocyte infiltration in sterile inflammation and cancer. Herein, we show that early immune cell accumulation at the peritoneal site of infection by mouse cytomegalovirus (MCMV) is mediated by IL-17D. Mice deficient in IL-17D or the transcription factor Nuclear factor (erythroid-derived 2)-like 2 (Nrf2), an inducer of IL-17D, featured an early decreased number of innate immune cells at the point of viral entry and were more susceptible to MCMV infection. Interestingly, we were able to artificially induce innate leukocyte infiltration by applying the Nrf2 activator tert-butylhydroquinone (tBHQ), which rendered mice less susceptible to MCMV infection. Our results implicate the Nrf2/IL-17D axis as a sensor of viral infection and suggest therapeutic benefit in boosting this pathway to promote innate antiviral responses. Nature Publishing Group UK 2018-09-12 /pmc/articles/PMC6135835/ /pubmed/30209334 http://dx.doi.org/10.1038/s41598-018-32011-2 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Seelige, Ruth Saddawi-Konefka, Robert Adams, Nicholas M. Picarda, Gaëlle Sun, Joseph C. Benedict, Chris A. Bui, Jack D. Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection |
title | Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection |
title_full | Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection |
title_fullStr | Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection |
title_full_unstemmed | Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection |
title_short | Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection |
title_sort | interleukin-17d and nrf2 mediate initial innate immune cell recruitment and restrict mcmv infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135835/ https://www.ncbi.nlm.nih.gov/pubmed/30209334 http://dx.doi.org/10.1038/s41598-018-32011-2 |
work_keys_str_mv | AT seeligeruth interleukin17dandnrf2mediateinitialinnateimmunecellrecruitmentandrestrictmcmvinfection AT saddawikonefkarobert interleukin17dandnrf2mediateinitialinnateimmunecellrecruitmentandrestrictmcmvinfection AT adamsnicholasm interleukin17dandnrf2mediateinitialinnateimmunecellrecruitmentandrestrictmcmvinfection AT picardagaelle interleukin17dandnrf2mediateinitialinnateimmunecellrecruitmentandrestrictmcmvinfection AT sunjosephc interleukin17dandnrf2mediateinitialinnateimmunecellrecruitmentandrestrictmcmvinfection AT benedictchrisa interleukin17dandnrf2mediateinitialinnateimmunecellrecruitmentandrestrictmcmvinfection AT buijackd interleukin17dandnrf2mediateinitialinnateimmunecellrecruitmentandrestrictmcmvinfection |